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ABSTRACT 
Objective: Residual solvents are undesirable components present in Active Pharmaceutical Ingredients (API), excipients, or drug products. To meet the 
specific quality-based requirements, the presence of these solvents in pharmaceutical products should be monitored to ensure their safety. The main 
objective of this work is to develop a new method for the determination of residual solvents in netupitant API by an HS-GC method with an FID detector. 
Methods: An automated headspace GC method has been developed and validated for the estimation of the residual solvents-N-methyl pyrrolidine, 
xylene, toluene, and N, N Dimethylacetamide in netupitant API. The samples were dissolved in dimethyl sulfoxide and the equilibrium headspace gas 
was formed at 80 ᵒC, which was analyzed using a DB-624 column (30m*0.53 mm, 3.00 µm) with an injector and detector temperature set at 160 ᵒC 
and 230 ᵒC, respectively. The initial oven temperature was set at 60 ᵒC for 5 min and programmed at a rate of 10 ᵒC/min to the final temperature of 
150 ᵒC, with a hold time of 5 min by maintaining the flow rate of 4.0 ml/min with a split ratio of 1:10, and total run time of 20 min. Nitrogen was 
used as carrier gas. The method developed was validated as per International Conference for Harmonization (ICH) guidelines for repeatability, 
linearity, range, ruggedness, detection limit, quantification limit, and recovery studies. 
Results: The linearity range selected was 50-350µg/ml and the correlation coefficient(γ2) values for all the solvents were found to be>0.99; 
recovery studies values were in a range of 90-110% and %RSD values were also found to be not more than 10 for the solvents. 
Conclusion: A novel, accurate, sensitive, and simple method was described for estimating residual solvents in Netupitant API by Headspace Gas 
Chromatography (HS-GC) coupled with a Flame Ionization Detector (FID). Excellent results have been observed for all the validated parameters 
with good peak resolution and lesser retention times. 
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INTRODUCTION 
Residual solvents are organic volatile impurities that are used or formed 
in different processes of synthesis or manufacture of pharmaceutical 
drug substances, intermediates, excipients, or drug products [1]. These 
solvents are toxic, possess no therapeutic importance, and may affect the 
quality and stability of the drug substances and drug products, because 
of which their presence is highly not acceptable in the final product. The 
selection of solvent for enhancing the yield of drug substance or for 
determining the characteristics like crystal form, solubility, and purity 
may sometimes be a crucial parameter in the synthesis process [2]. Even 
after subjecting too many common techniques like increased process 
temperature or decreasing pressure that are used in general 
manufacturing processes, they are completely not removed [3, 4]. ICH 
guideline Q3C(R6) recommends the use of less toxic solvents and 
acceptable amounts for residual solvents in pharmaceuticals for the 
safety of the patient and also, the amount of solvent present should be 
evaluated and justified [5]. The term “permitted daily exposure” (PDE) 
was defined in this guideline as a pharmaceutically acceptable intake of 
residual solvents [5]. After evaluation, if the calculated values are equal 
to or below the recommended/acceptable level, no testing for the 
residual solvents in the drug product is needed and is safe for human 
use; and if the calculated values are above the recommended/acceptable 
level, then the drug product should undergo testing for ensuring the 
safety of that particular drug for human use [5]. 
The most commonly used method for estimation of residual solvents is 
static HS-GC with FID detector in pharmaceuticals. The reasons why this 
method is preferred for validation over other analytical techniques are, 
(i) its fully automated, (ii) sample preparation is easy, (iii) high 
separation efficiency, and (iv)sensitivity for volatile organic solvent [6, 
7]. All these advantages for HS-GC have made it the most important tool 
in determining and quantifying the residual solvents. 
In general, 25% to 30% of patients with a diagnosis of cancer receive 
chemotherapy as treatment. Out of these, 70%-80% experience one 
of the most distressing side effects, nausea, and vomiting which has 
an immense impact on the quality of life of patients receiving certain 
antineoplastic therapies [8]. Netupitant is a potential antiemetic 
drug that acts as a selective neurokinin1 (NK 1) receptor antagonist. 
It competitively binds to and also blocks the activity of human 
substance P/NK 1 receptors in the central nervous system (CNS), 
then inhibiting NK-1 receptor binding of endogenous tachykinin 
neuropeptide substance P(SP), which thereby results in the 
prevention of chemotherapy-induced nausea and vomiting (CINV) 
[8]. This drug was approved in October 2014 by FDA for use in 
combination with palonosetron for the prevention of acute and 
delayed vomiting and nausea associated with cancer chemotherapy, 
including highly emetogenic chemotherapy [9]. 
 
 
Fig. 1: Structure of netupitant [10] 
 
From the scheme of synthesis for Netupitant [8], residual solvents-
toluene, xylene, N, N-dimethylacetamide, and N-methyl pyrrolidine 
were used in the synthesis and purification process of the drug. 
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These solvents in the drug product are needed to be validated and 
quantified to ensure their safety for human use. The present study 
mainly focuses on the novel method development and validation for 
the estimation of residual solvents in Netupitant API by the HS-GC 
method with FID detection. 
MATERIALS AND METHODS 
Materials 
All the chemicals used were of GC Grade. N-methyl pyrrolidine and 
N, N-dimethylacetamide were obtained from Qualigens, Mumbai. 
Xylene, toluene, and dimethyl sulfoxide were obtained from Sigma 
Aldrich, Bengaluru. Netupitant API was a gift sample obtained from 
Chandra Labs, Hyderabad. 
Instrument details 
Work was studied on Agilent Infinity 7697A Head Space Gas 
Chromatography with flame ionization detector and the software 
used was Open labs EZChrome Software. For weighing, Mettler 
Toledo precision balance was used. 
Method development 
The headspace GC method has been developed stepwise 
systematically [11]. In the first trial, DB-620(80m*0.22 mm, 1.8 µm) 
column was taken, where injection temperature and the detector 
temperature were set to 180 ᵒC and 230 ᵒC respectively with an 
initial oven temperature 80 ᵒC and programmed at the rate of 10 
ᵒC/min to the final temperature of 180 ᵒC with a flow rate of 2.0 
ml/min. Headspace equilibrium temperature was taken as 80 ᵒC 
with a run time of 35 min. The merging of peaks N-methyl acetamide 
and xylene have been observed. Hence optimization of the method is 
required for good separation of peaks. 
For the next trial, DB-624(50m*0.22 mm,1.8 µm) column was taken, 
where injection temperature and detector temperature were set to 
160 ᵒC and 230 ᵒC respectively with the initial temperature of 70 ᵒC 
and programmed at the rate of 10 ᵒC/min to the final temperature of 
150 ᵒC with flow rate 3.0 ml/min. Headspace equilibrium 
temperature was 80 ᵒC with a total run time 30 min. In this trial, 
separation was achieved, but a poor resolution was observed. Hence, 
further optimization was required to fulfill a good resolution. 
In the final trial, DB-624(30m*0.53, 3.0 µm) was taken, where 
injection temperature and detector temperature were set to 160 ᵒC 
and 230 ᵒC respectively with the initial temperature of 60 ᵒC and 
programmed at the rate of 10 ᵒC/min to the final temperature of 150 
ᵒC with flow rate 4.0 ml/min. Headspace equilibrium temperature 
was 80 ᵒC with a total run time 20 min. The separation of peaks with 
a good resolution has been observed in this trial. 
Optimization details 
Column selection is a very crucial parameter for achieving good 
separation in GC analysis. For getting effective results, some columns 
were investigated. For the first and second columns, the response 
was found to be unsatisfactory with poor resolution. More 
optimization was required, which was fulfilled by the third column. 
This column has shown good peak resolution with lesser retention 
time. Therefore, DB-624(30m*0.53 mm, 1.8 µm) was selected for 
carrying out this study. The selection of temperature is also one of 
the important factors in achieving good resolution as the utmost 
care has to be taken that the analyte is not degraded in the complete 
analysis [12]. The injection temperature was changed from 180 ᵒC to 
160 ᵒC and the oven initial and final temperatures have fluctuated 
from 60 ᵒC-80 ᵒC and 150 ᵒC-150 ᵒC, respectively. Control of flow 
rate also determines the resolution of peaks. The flow rate was 
varied from 2.0 ml/min-4.0 ml/min to get a good resolution of 
peaks. Because of making few deliberate changes in these 
parameters, good resolution of peaks with lesser retention times has 
been observed. The optimized chromatographic conditions were 
inlet temperature was 160 ᵒC and detector temperature was 230 ᵒC. 
The column used was DB-624 (30m×0.53 mm, 3.0 µm) column. The 
initial oven temperature was kept at 60 ᵒC for 5 min and the final 
oven temperature was 150 ᵒC, increasing @ 10 ᵒC/min withhold 
time 5 min. The flow rate was 4.0 ml/min with a split ratio of 1:10. 
The carrier gas used was nitrogen. Headspace optimized conditions 
for oven temperature, transfer line temperature, and loop fill 
temperature were found to be 80 ᵒC, 90 ᵒC, and 100 ᵒC, respectively. 
The total run time was 20 min. 
Procedure 
These studies were carried out at 25 ᵒC. The solubility of Netupitant 
was found to be more in dimethyl sulfoxide; hence it is used as diluent. 
Preparation of blank solution 
Transferred 1.0 ml of diluent in headspace vial and sealed the vial 
immediately. 
Preparation of standard solution 
Weighed accurately 500 mg of xylene, 500 mg of toluene, 500 mg of 
N, N-dimethylacetamide, and 500 mg of N-methyl pyrrolidine in 200 
ml volumetric flask containing about 80 ml of diluent and then made 
up the volume with diluent and shaken well. 
Preparation of working standard solution 
From the standard solution, 10 ml was pipetted out into a 200 ml 
volumetric flask containing about 20 ml diluent. Made up the volume 
with diluent. Pipetted out 1 ml of the above-prepared solution in the 
headspace vial and sealed the vial immediately. 
Preparation of test solution 
Weighed accurately 500 mg of the test sample (Netupitant API) and 
transferred it to a 50 ml volumetric flask containing 35 ml diluent, 
vortexed it for 5 min. Then the volume was made up with the diluent 
and mixed well. Pipetted out 1.0 ml of the above-prepared solution 
in the headspace vial and sealed the vial immediately. 
Experimental 
Transferred the above-prepared solutions into headspace vials, sealed 
immediately and injected into the system; and used as per the 
procedures mentioned in ICH guidelines for validating the parameter for 
evaluating the residual solvents. To avoid excessive peak broadening, 
adequate flow should be maintained throughout the system. 
RESULTS  
In this study, the HS-GC method has been developed and validated 
for the quantitative determination of residual solvents xylene, 
toluene, N, N-dimethylacetamide, and N-methyl pyrrolidine in 
Netupitant API. The validation was done as per ICH guidelines by 
using standard addition with internal standard quantitation for the 
estimation of four residual solvents. Specificity (by direct 
comparison method), detection and quantification limits, linearity 
and repeatability, recovery (75%, 100% and 150%), robustness 
(changing oven temperature), and ruggedness (analyst change) 
were determined. The results obtained were excellent. The method 
validated has shown good reproducibility, recovery, and linearity; 
justified the preparation of standard in dimethyl sulfoxide with high 
resolution and lesser retention time. 
Specificity 
Specificity is determined by the direct comparison method. DB-
624(30m×0.53 mm, 3 µm) column has been selected because it has a 
standard stationary phase as recommended by different 
pharmacopeias. It has been observed that diluent or API peaks are not 
interfering at the retention times of the solvent peaks i.e.; xylene, 
toluene, N, N-dimethylacetamide, and N-methyl Pyrrolidine and have 
shown excellent peak resolution, which resulted in good column 
efficiency (fig. 2 and 3). Hence the method was found specific. 
System suitability, method precision, and repeatability 
The procedure was carried out as mentioned in ICH guidelines for 
determining the system suitability and method precision. Six 
independent determinations were carried out, by individually 
weighing the amounts of the solvents, and %RSD values were 
calculated. For repeatability studies, the same procedure was 
followed by different analysts, and %RSD was calculated. Acceptance 
criteria were %RSD should be not more than 10% and observed 
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values for each solvent were found to be less than 10%. This 
indicates that the proposed method passed system suitability testing 
and has shown good reproducibility and repeatability (table 1). The 
result indicates the method was capable with high precision. And 
also, good separations were achieved, which suggests that the 
method was selective for all components under the test. 
 
 
Fig. 2: Chromatogram for the specificity of standards 
 
 
Fig. 3: Chromatogram for the specificity of blank 
 
Table 1: Method precision and intermediate precision data 
Solvent Method precision intermediate precision 
mean±SEM %RSD mean±SEM %RSD 
N-Methyl Pyrrolidine 1090.24±20.93 4.70 1034.98±4.74 1.12 
N, N- Dimethyl Acetamide 5119.24±68.67 3.29 4804.00±40.59 2.08 
Xylene 15642.12±341.55 5.35 12739.6±291.33 5.93 
Toluene 5080.73±44.11 2.13 4746.62±31.04 1.60 
*mean±SEM denotes the reliability of data at 95% confidence interval with z-value 1.960, SEM is the standard error of mean which is calculated by, 
σ/(n)½; where σ is the standard deviation for the residual solvents and n, a number of injections=6; and RSD is the relative standard deviation.  
 
 
Fig. 4: Linearity curve for N-methyl pyrrolidine 
 
 
Fig. 5: Linearity curve for xylene 
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Fig. 6: Linearity curve for toluene 
 
 
Fig. 7: Linearity curve for N, N-dimethylacetamide 
 
Linearity studies 
This study was carried out by taking five different standard 
solutions ranging from 50µg/ml to 350µg/ml that were prepared for 
each solvent. The results obtained were represented in a calibration 
curve and a statistical study was carried out. This relationship of 
concentrations with responses of each solvent should be linear 
within the specified range with a correlation coefficient not less than 
0.99. It was observed that this method was linear within a wider 
range for all the solvents which are in the validation. The correlation 
coefficient for each solvent was found to be>0.99 and also linear 
regression has shown a positive response throughout the range 
(table 2). The range is normally derived from linearity studies. 
Detection and quantification limits 
Detection limit and quantification limit values were calculated as 
those concentrations that gave S/N ratio 3 and ≥10 respectively and 
give low residual linearity values. Six independent determinations 
were carried out for determining the limit of detection (LOD) and 
limit of quantification (LOQ) values by diluting the standard solution 
and spiked on the diluent and injected into HS-GC (table 2). 
 
Table 2: Residual solvents validation results 
Solvent Specificity RT (mins) Linearity γ2 LOD (µg/ml) LOQ (µg/ml) 
N-Methyl Pyrrolidine 2.02 0.990 30.83 93.44 
N,N-Dimethyl acetamide 4.39 0.995 21.07 63.83 
Xylene 5.22 0.992 26.26 79.58 
Toluene 8.10 0.993 12.86 38.97 
*RT denotes retention time in minutes, γ2denotes correlation coefficient, LOD and LOQ are limits of detection and quantification respectively 
measured in µg/ml. 
 
Table 3: System suitability under robustness 
Conditions N-methyl pyrrolidine  N, N-dimethyl acetamide  Xylene  Toluene  
mean±SEM %RSD mean±SEM %RSD mean±SEM %RSD  mean±SEM %RSD 
Control 1090.24±20.93 4.70 5119.24±68.67 3.29 15642.12±341.55 5.35 5080.73±44.11 2.13 
High oven temperature 10777.6±5.14 0.83 4927.64±40.62 1.43 13710.71±330.24 4.28 4987.7±26.79 0.93 
Low oven temperature 633.47±11.82 3.13 2749.61±68.53 4.16 7489.7±305.5 6.74 2557.56±58.9 3.85 
*mean±SEM values at 95% confidence interval with z-Value 1.960 for all the residual solvents where n, number of injections=3 is calculated and RSD 
is relative standard deviation value. 
 
Robustness 
Robustness was performed by changing the oven temperature for 
which the %RSD values observed were not more than 10 and within 
the acceptance criteria (table 3). Hence the method was found to be 
robust with concern to changes made deliberately. 
Accuracy (Recovery studies) 
The accuracy of the method was determined by the standard addition 
method at 3 levels. To the API at the quantitation limit (QL) the solvents 
were added at the level of 75%, 100%, and 150%. The recovery studies 
were carried out in triplicate and percentage recovery and percentage 
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mean recovery were calculated for the drug and solvents. All the values 
were found to be between 90-110% which is very much in acceptance 
within the prescribed limits i.e.; % recovery should be within 80-120% 
according to the ICH guidelines (table 4). 
 
Table 4: Recovery studies or accuracy data 
Spiking level 
(% of QL) 
N-Methyl pyrrolidine 
(%recovery) 
N, N-Dimethyl acetamide 
(%recovery) 
Toluene (%recovery) Xylene (%recovery) 
75% 93.08 90.17 117.02 91.42 
100% 96.56 98.02 105.63 96.86 
150% 103.89 107.06 107.97 106.89 
*QL denotes quantification limit at the spiked level 
 
Table 5: Summary of validation parameters for the method developed 
Specificity Diluent or API peaks are not interfering with the retention times of solvent peaks 
Linearity γ2≥0.99 
Method Precision(%RSD) 2.13-4.70 
Intermediate Precision(%RSD) 1.12-5.93 
Accuracy (% Recovery) 90.17-117.02 
Detection Limit 12.86-30.84 
Quantification Limit 38.97-93.44 
Ruggedness %RSD for all the solvents were within the acceptance limits 
Robustness %RSD for all the solvent peak areas and content in µg/ml is within the acceptance limits 
 
DISCUSSION 
In this study, a novel chromatographic method has been developed 
and validated for the estimation of residual solvents in Netupitant 
API. Few analytical methods have been reported for the estimation 
of Netupitant [9, 13]. However, the HS-GC method has not been 
reported earlier for Netupitant API. 
Method development for optimizing the chromatographic conditions 
has been a very crucial step. Trails were done and the optimized 
method was found to be feasible and easily adaptable. Compared to 
other analytical methods, HS-GC generally takes a longer time to 
complete the analysis [4, 6, 7, 11, 12]. In contrast, this method’s GC 
run time was 20 min which indicates that the estimation of residual 
solvents in Netupitant API can be carried out rapidly and efficiently.  
The retention times for the N-methyl pyrrolidine, N, N-Dimethyl 
acetamide, xylene, and toluene were 2.02, 4.39, 5.22, and 8.10 
respectively. Compared to other GC methods for these solvents, the 
retention times observed in this method were less [4, 6, 7, 11, 12, 15, 
16]. There was no interference of dissolving solvent peak at the 
retention times to that of solvent peaks. Fig. 2 and 3 show all peaks 
well resolved, hence the method was found to be specific.  
Tables 1 and 3 show all %RSD values not more than 10% for 
precision, intermediate precision, and system suitability testing. The 
data was reported in mean±SEM values which signifies the reliability 
of the results. From tables 4 and 5, the percentage recovery for each 
solvent at 75%, 100% and, 150% was found to be in the range of 90-
120% which is very much in acceptance with ICH specified limits. 
From the above-obtained results, it was proved that the developed 
method is more accurate and precise.  
The linear relationship was evaluated across the range of 
concentration of analyte solvents (50µg/ml-350µg/ml) and 
calculated correlation coefficient values were found to be γ2>0.99 
(fig. 4-7 and Tables 2 and 5). LOD and LOQ values for each solvent 
were found to be satisfactory (table 2 and 5). By introducing 
deliberate changes in the system, made no or very negligible 
difference as the RSD values remained<10% for all the solvents 
(table 3 and 5). All the obtained results for the validation parameters 
met the ICH accepted criteria. In comparison to other reported HS-
GC methods [4-7, 11, 12, 14-16], this method was found to be more 
specific, reliable and, accurate. Hence, it can be effectively applied 
for routine analysis in research institutions.  
CONCLUSION 
By observing the results and summarized validation parameters, it 
was concluded that the newly developed method for the estimation of 
residual solvents N-Methyl Pyrrolidine, N, N-Dimethyl Acetamide, 
xylene, and toluene in Netupitant API was found to be accurate, simple, 
precise, with high resolution and lesser retention time which makes 
this method very much acceptable and economical. It can be effectively 
applied in quality control departments in industries, approved testing 
laboratories, bio-pharmaceutical, and bioequivalence studies, and also 
in pharmacokinetic studies in near future. 
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